Artiva Biotherapeutics ARTV
NASDAQ ARTV
$7.16 +0.13 (+1.78%)
As of: Sep 30, 2026 · 10:20 AM EDT

Artiva Biotherapeutics (ARTV) Operating Margin (2023 - 2024)

Updated

Artiva Biotherapeutics (ARTV) posted Operating Margin of -26805.58% for FY2024, down 26714.00 percentage points from -91.58% in FY2023.

Analysis

Artiva Biotherapeutics (ARTV) Operating Margin (2023 - 2024) Analysis & Trends

  • Business Quant data shows ARTV's Operating Margin at -91.58% in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Artiva Biotherapeutics 277.86 Mn 277.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -5,773.71%
Dec 31, 2023 -509.36%
Sep 30, 2023 40.56%
Jun 30, 2023 -338.12%
API Access

Artiva Biotherapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=ARTV&period=max&api_key=YOUR_API_KEY